Adjusting therapeutic dosage regimens to optimise the balance of benefit to harm.

Adjusting therapeutic dosage regimens to optimise the balance of benefit to harm.

Dosage regimens should generally be individualised, depending on features of the patient that can alter the drug's pharmacokinetics (disposition in the body) or pharmacodynamics (therapeutic and adverse effects). It is usually good practice to start with a low dose, gradually increasing it acco...

Полное описание

Библиографические подробности
Главный автор:	Aronson, J
Формат:	Journal article
Язык:	English
Опубликовано:	2005

Схожие документы

Assessing perceptions of benefit and harm of common drug therapies using therapeutic scenarios
по: Aronson, J, и др.
Опубликовано: (2003)

Inhibiting the proton pump: mechanisms, benefits, harms, and questions
по: Aronson, J
Опубликовано: (2016)

Balancing benefits and harms in health care.
по: Cuervo, L, и др.
Опубликовано: (2003)

Lorcaserin in obesity: minimal benefits and ill-defined harms
по: Onakpoya, I, и др.
Опубликовано: (2019)

ON THE SELECTION OF DRUGS DOSAGE REGIMEN
по: E. N. Bochanova
Опубликовано: (2015-09-01)

ON THE SELECTION OF DRUGS DOSAGE REGIMEN
по: E. N. Bochanova
Опубликовано: (2015-09-01)

Patentability of Pharmaceutical Dosage Regimens in Europe
по: Mahdi Zahedi, и др.
Опубликовано: (2013-03-01)

Application of Monte Carlo simulation to optimise the dosage regimen of meropenem in patients with augmented renal clearance for Pseudomonas aeruginosa infection
по: Jia Hou, и др.
Опубликовано: (2024-06-01)

Increasing Risks to the Health of the Invertebrates—Balancing between Harm and Benefit
по: Tatiana V. Kuznetsova, и др.
Опубликовано: (2024-05-01)

ChatGPT and mental healthcare: balancing benefits with risks of harms
по: John Torous, и др.
Опубликовано: (2023-10-01)

Balance of benefits and harms of different blood pressure targets in people with multiple chronic conditions: a quantitative benefit-harm assessment
по: Bruce Leff, и др.
Опубликовано: (2019-08-01)

Laughter and MIRTH (Methodical Investigation of Risibility, Therapeutic and Harmful): narrative synthesis.
по: Ferner, R, и др.
Опубликовано: (2013)

The appropriate use of human albumin in a Brazilian University Hospital: therapeutic indication and dosage regimen
по: Tatiane Sayuri Ishida, и др.
Опубликовано: (2019-04-01)

Suicide, depression, and antidepressants - Patients and clinicians need to balance benefits and harms
по: Cipriani, A, и др.
Опубликовано: (2005)

Predicted Vancomycin Dosage Requirement in Patients With Hematological Malignancies and Dosage Dynamic Adjustment
по: Xiangqing Song, и др.
Опубликовано: (2022-06-01)

Monitoring for harms of therapy.
по: Aronson, J
Опубликовано: (2006)

Individualized antibiotic dosage regimens for patients with augmented renal clearance
по: A-Xi Shi, и др.
Опубликовано: (2023-07-01)

Optimizing vancomycin dosage regimen at the University Medical Center Maribor
по: Maja Cvikl, и др.
Опубликовано: (2011-12-01)

DISPOSITION KINETICS AND DOSAGE REGIMEN OF INTRAVENOUSLY INJECTED KANAMYCIN IN BUFFALOES
по: T. Saeed, R. Ahmad, M. Nawaz1 and T. Iqbal
Опубликовано: (2000-01-01)

Dosage regimen and toxicity risk assessment of linezolid in sepsis patients
по: Linjie Dou, и др.
Опубликовано: (2020-07-01)

Dosage adjustment in renal insufficiency: comparison between databases
по: Isabella Faria MARANHÃO, и др.
Опубликовано: (2024-03-01)

Female-specific pharmacotherapy in ADHD: premenstrual adjustment of psychostimulant dosage
по: M. de Jong, и др.
Опубликовано: (2023-12-01)

Precision Oncology by Point-of-Care Therapeutic Drug Monitoring and Dosage Adjustment of Conventional Cytotoxic Chemotherapies: A Perspective
по: Myriam Briki, и др.
Опубликовано: (2023-04-01)

Adverse drug reactions--no farewell to harms.
по: Aronson, J
Опубликовано: (2007)

Scheduled dosage regimen by irreversible electroporation of loaded erythrocytes for cancer treatment
по: Wencheng Peng, и др.
Опубликовано: (2023-12-01)

Population Pharmacokinetic Modeling of Zaltoprofen in Healthy Adults: Exploring the Dosage Regimen
по: Ji-Hun Jang, и др.
Опубликовано: (2023-01-01)

Chloroquine dosage regimen simulation for pediatric patients with coronavirus disease 2019
по: Kiatkriangkrai Koyratkoson, и др.
Опубликовано: (2022-07-01)

Market harms and market benefits
по: Wilkinson, H
Опубликовано: (2022)

Balance between solitude and socializing: everyday solitude time both benefits and harms well-being
по: Netta Weinstein, и др.
Опубликовано: (2023-12-01)

Tylosin Dosage Adjustment Based on Allometric Scaling in Male Turkeys
по: Błażej Poźniak, и др.
Опубликовано: (2021-08-01)

Optimising dosage of Lytag used as coarse aggregate in lightweight aggregate concretes
по: S Ahmad, и др.
Опубликовано: (2013-04-01)

Dose optimization of TBI-223 for enhanced therapeutic benefit compared to linezolid in antituberculosis regimen
по: Natasha Strydom, и др.
Опубликовано: (2024-08-01)

Benefits and harms in pivotal trials of oral centrally acting antiobesity medicines: A systematic review and meta-analysis.
по: Onakpoya, I, и др.
Опубликовано: (2018)

Optimisation of BMP-2 dosage for the osseointegration of porous titanium implants in an ovine model
по: EB Hunziker, и др.
Опубликовано: (2016-11-01)

Optimization of Pharmacotherapy with Direct Oral Anticoagulants: the Need to Choose the Right Dosage Regimen
по: A. I. Kochetkov, и др.
Опубликовано: (2019-09-01)

Individualization of the Dosage Regimen of Erythropoietin is Crucial in End-stage Renal Disease Patients
по: M. K. Krishnapriya, и др.
Опубликовано: (2023-03-01)

A proposal for an individualized pharmacogenetic-guided isoniazid dosage regimen for patients with tuberculosis
по: Jung JA, и др.
Опубликовано: (2015-09-01)

Assessment of knowledge among caregivers of diabetic patients in insulin dosage regimen and administration
по: Lamya Alnaim, и др.
Опубликовано: (2021-10-01)

Influence of potential gene polymorphisms on propofol dosage regimen in patients undergoing abdominal hysterectomy
по: Ivanov E, и др.
Опубликовано: (2021-03-01)

Individually tailored dosage regimen of full-spectrum Cannabis extracts for autistic core and comorbid symptoms: a real-life report of multi-symptomatic benefits
по: Patrícia Soares Silva Montagner, и др.
Опубликовано: (2023-08-01)